UA96282C2 - 3,5-substitgued piperidine compounds as renin inhibitors - Google Patents

3,5-substitgued piperidine compounds as renin inhibitors

Info

Publication number
UA96282C2
UA96282C2 UAA200808524A UAA200808524A UA96282C2 UA 96282 C2 UA96282 C2 UA 96282C2 UA A200808524 A UAA200808524 A UA A200808524A UA A200808524 A UAA200808524 A UA A200808524A UA 96282 C2 UA96282 C2 UA 96282C2
Authority
UA
Ukraine
Prior art keywords
treatment
compound
renin
substituted piperidine
disease
Prior art date
Application number
UAA200808524A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Такеру Эхара
Филипп Гроше
Осаму Ирие
Юки Иваки
Таканори Каназава
Шимпеи Каваками
Казухиде Кониши
Мунето Моги
Масаки Сузуки
Фумиаки Йококава
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of UA96282C2 publication Critical patent/UA96282C2/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3, 5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The preferred compounds (which can also be present as salts) have the formula (I’), wherein R1 , R2, T, R3 and R4 are as defined in the specification., (I’)
UAA200808524A 2005-12-30 2006-12-28 3,5-substitgued piperidine compounds as renin inhibitors UA96282C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05028771 2005-12-30

Publications (1)

Publication Number Publication Date
UA96282C2 true UA96282C2 (en) 2011-10-25

Family

ID=40391423

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200808524A UA96282C2 (en) 2005-12-30 2006-12-28 3,5-substitgued piperidine compounds as renin inhibitors

Country Status (4)

Country Link
CN (1) CN101365680A (en)
TN (1) TNSN08287A1 (en)
UA (1) UA96282C2 (en)
ZA (1) ZA200804956B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106414396B (en) * 2014-04-10 2019-11-08 武田药品工业株式会社 The method for preparing heterocyclic compound
US10550087B2 (en) * 2015-11-17 2020-02-04 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof

Also Published As

Publication number Publication date
TNSN08287A1 (en) 2009-10-30
CN101365680A (en) 2009-02-11
ZA200804956B (en) 2009-05-27

Similar Documents

Publication Publication Date Title
TW200738698A (en) Organic compounds
TNSN07361A1 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
WO2007006534A3 (en) Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity
MX2007011009A (en) Organic compounds.
TW200635915A (en) Organic compounds
BRPI0519443A2 (en) organic compounds
WO2006125621A8 (en) Substituted piperidines as renin inhibitors
MX2007005644A (en) 1,4 substituted pyrazolopyrimidines as kinase inhibitors.
WO2006074924A8 (en) 3,4,(5)-substituted tetrahvdropyridines
WO2006072589A3 (en) Disubstituted ureas as kinase inhibitors
WO2006018182A8 (en) Combinations for the treatment of diseases involving cell proliferation
NO20056192L (en) Capase inhibitors and their use
WO2006044497A3 (en) Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
EP1817312A4 (en) Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
ATE307810T1 (en) IMIDAZOLE-2-CARBONIC ACID AMIDE DERIVATIVES AS RAF-KINASE INHIBITORS
WO2006128659A3 (en) Piperazine derivative renin inhibitors.
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
TNSN06150A1 (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
ATE543803T1 (en) 3-Ä2-(3-AZYLAMINO-2-OXO-2H-PYRIDINE-1-YL)ACETYLAMINOÜ-4-OXOPENTANIC ACID DERIVATIVES AND THEIR USE AS CASPASE INHIBITORS
WO2004046122A3 (en) Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
MXPA05010020A (en) Oxamide derivatives useful as raf-kinase inhibitors.
TW200800966A (en) Beta-secretase modulators and methods of use
UA96282C2 (en) 3,5-substitgued piperidine compounds as renin inhibitors